ZADAXIN® 1,6 mg/ml clinical trials

A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients

This study is looking at a new treatment called Thymosin alpha 1 (brand name ZADAXIN®) for cystic fibrosis. It wants to see if this treatment can reduce inflammation in the lungs and if it's safe for patients. Researchers will check levels of inflammation markers in sputum and monitor overall health.